בריפלקס PN 250
देश: इसराइल
भाषा: हिब्रू
स्रोत: Ministry of Health
अनुरोध भेजा।
सक्रिय संघटक:
COAGULATION FACTOR II (HUMAN); COAGULATION FACTOR IX (HUMAN- RFIXFC); COAGULATION FACTOR VII (HUMAN); COAGULATION FACTOR X (HUMAN); PROTEIN C; PROTEIN S ANTIGEN
थमां उपलब्ध:
CSL BEHRING LTD., ISRAEL
ए.टी.सी कोड:
B02BD01
फार्मास्यूटिकल फॉर्म:
אבקה וממס להכנת תמיסה להזרקה
रचना:
COAGULATION FACTOR II (HUMAN) 200 - 480 IU; COAGULATION FACTOR VII (HUMAN) 100 - 250 IU; COAGULATION FACTOR IX (HUMAN- RFIXFC) 200 - 310 IU; COAGULATION FACTOR X (HUMAN) 220 - 600 IU; PROTEIN C 150 - 450 IU; PROTEIN S ANTIGEN 120 - 380 IU
प्रशासन का मार्ग:
תוך-ורידי
प्रिस्क्रिप्शन प्रकार:
מרשם נדרש
द्वारा बनाया गया:
CSL BEHRING GmbH, GERMANY
चिकित्सीय समूह:
COAGULATION FACTOR IX, II, VII AND X IN COMBINATION
चिकित्सीय क्षेत्र:
COAGULATION FACTOR IX, II, VII AND X IN COMBINATION
चिकित्सीय संकेत:
-Treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin K antagonists, or in case of overdose of vitamin K antagonists, when rapid correction of the deficiency is required.
प्राधिकरण की तारीख:
2017-03-31
